TMCnet News

CFX, HDB, IDIX, KRO, HITK, MGEE Are Seasonally Ripe To Go Up In the Next Five Weeks
[July 17, 2013]

CFX, HDB, IDIX, KRO, HITK, MGEE Are Seasonally Ripe To Go Up In the Next Five Weeks


Jul 17, 2013 (M2 PRESSWIRE via COMTEX) -- BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Canfor Pulp Products Inc (NYSE:CFX), HDFC Bank Ltd (NYSE:HDB), Idenix Pharmaceuticals Inc (NASDAQ:IDIX), Kronos Worldwide Inc (NYSE:KRO), Hi-Tech Pharmacal Co Inc (NASDAQ:HITK), MGE Energy Inc (NASDAQ:MGEE) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/strat/mh.php The following stocks are expected to go Up: Symbol Company Expected Return Odds By The Following Date CFX Canfor Pulp Products Inc 8.68% 100.00% (5 of 5) Tuesday, July 30th 2013 HDB HDFC Bank Ltd 3.07% 90.91% (10 of 11) Thursday, July 18th 2013 IDIX Idenix Pharmaceuticals Inc 4.24% 100.00% (8 of 8) Thursday, July 18th 2013 KRO Kronos Worldwide Inc 3.05% 100.00% (9 of 9) Thursday, July 18th 2013 HITK Hi-Tech Pharmacal Co Inc 3.49% 84.62% (11 of 13) Thursday, July 18th 2013 MGEE MGE Energy Inc 3.20% 92.31% (12 of 13) Monday, August 26th 2013 Canfor Pulp Products Inc (NYSE:CFX) - Colfax Corporation, a diversified industrial manufacturing and engineering company, provides gas- and fluid-handling and fabrication technology products and services to commercial and governmental customers worldwide. The company operates two segments, Gas and Fluid Handling and Fabrication Technology. The Gas and Fluid Handling segment supplies a range of products, including pumps, fluid-handling systems and controls, specialty valves, heavy-duty centrifugal and axial fans, rotary heat exchangers and gas compressors, which serves customers in the power generation, oil, gas and petrochemical, mining, marine, defense, and general industrial and other end markets. It also provides repair and retrofit services for products manufactured by other valve suppliers. In addition, this segment provides lubrication system equipment and services, including LubriMist oil mist generators, Mistlock bearing lubrication cartridges, and ThermoJet oil purifiers, as well as high velocity oil flushing, leakage oil reclamation, and condition monitoring services to customers in petroleum, petrochemical, natural gas, and power generation end markets. It markets its products primarily under the Howden, Colfax Fluid Handling, Allweiler, Imo, and Total Lubrication Management brands. The Fabrication Technology segment formulates, develops, manufactures and supplies consumable products and equipment primarily under the ESAB brand for use in the cutting and joining of steels, aluminum, and other metals and metal alloys. Its ESAB range of welding consumables includes electrodes, cored and solid wires, and fluxes. The company markets its products through direct sales and third-party distribution channels. Colfax Corporation was founded in 1860 and is headquartered in Fulton, Maryland..



HDFC Bank Ltd (NYSE:HDB) - HDFC Bank Limited, together with its subsidiaries, provides retail banking, wholesale banking, treasury, and other financial services to individual and business customers in India. It offers various deposit products, including current accounts, savings accounts, salary accounts, fixed and recurring deposits, demat accounts, safe deposit lockers, and rural accounts; loan products comprising personal, home, car, two wheeler, educational, and rural loans, as well as loans against assets and government sponsored programs; credit, debit, and prepaid cards; travel, remittance, and other foreign exchange services; and private banking services. The company also provides stock broking services to access and trade in various investment products, such as equities, derivatives, currency futures, mutual funds, IPOs, bonds, corporate fixed deposits, and insurance products; equity Investment advice and an execution platform; and asset management services to manage various mutual funds, including children s gift funds, fund of fund schemes, debt/income funds, fixed maturity plans, equity/growth funds, liquid funds, exchange trade funds, and quarterly interval funds. In addition, it offers real estate services to facilitate buying, selling, or leasing of residential/commercial properties; life, health, motor, travel, home, personal accident, and commercial insurance products; and loans for business expansion, working capital requirements, school admissions, weddings, and vacations. As of March 31, 2012, the company operated a network of 2,544 branches and 8,913 ATMs in 1,399 cities. HDFC Bank Limited was founded in 1994 and is based in Mumbai, India..

Idenix Pharmaceuticals Inc (NASDAQ:IDIX) - Idenix Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of drugs for the treatment of human viral diseases in the United States and Europe. Its primary research and development focus is on the treatment of patients with hepatitis C virus (HCV). The company s HCV discovery program focuses on various classes of drugs, including nucleoside/nucleotide polymerase inhibitors, protease inhibitors, non-nucleoside polymerase inhibitors, and NS5A inhibitors. It develops products and drug candidates for the treatment of patients with hepatitis B virus (HBV), human immunodeficiency virus (HIV) type-1, and acquired immune deficiency syndrome (AIDS). The company principally has a collaboration agreement with Novartis Pharma AG for the development and commercialization of telbivudine, a drug for the treatment of HBV under the Tyzeka/Sebivo names. Idenix Pharmaceuticals, Inc. was founded in 1998 and is headquartered in Cambridge, Massachusetts..


Kronos Worldwide Inc (NYSE:KRO) - Kronos Worldwide, Inc. engages in the production and marketing of titanium dioxide pigments under the Kronos brand name primarily in North America and Europe. It produces titanium dioxide pigments in two crystalline forms, rutile and anatase to impart whiteness, brightness, opacity, and durability for products, such as coatings, plastics, papers fibers, and ceramics, as well as for various specialty products, including inks, food, and cosmetics. The company also offers ilmenite, a raw material used directly as a feedstock by sulfate-process titanium dioxide pigment plants; iron-based chemicals, which are co-products and processed co-products of the titanium dioxide pigment production process and used as treatment and conditioning agents for industrial effluents and municipal wastewater, as well as in the manufacture of iron pigments, cement, and agricultural products; and titanium oxychloride and titanyl sulfate, which are side-stream products from the production of titanium dioxide pigments. Its titanium oxychloride is used in the formulation of pearlescent pigments and production of electroceramic capacitors for cell phones and other electronic devices; and titanyl sulfate is used in pearlescent pigments, natural gas pipe, and other specialty applications. In addition, the company provides technical services. Kronos Worldwide, Inc. sells its products through distributors and agents to paint, plastics, decorative laminate, and paper manufacturers. The company was founded in 1989 and is headquartered in Dallas, Texas. Kronos Worldwide, Inc. is a subsidiary of Valhi, Inc..

Hi-Tech Pharmacal Co Inc (NASDAQ:HITK) - Hi Tech Pharmacal Co., Inc., a specialty pharmaceutical company, engages in developing, manufacturing, and marketing prescription, over-the-counter (OTC), and nutritional products in the United States. The company offers a range of products for various disease states, including glaucoma, asthma, bronchial disorders, dermatological disorders, allergies, pain, stomach, and oral care. Its generic pharmaceutical products include oral solutions and suspensions, topical creams and ointments, and nasal sprays. The company also manufactures liquid ophthalmic, otic, and inhalation products. In addition, it markets a line of OTC branded products, such as Diabetic Tussin, DiabetiDerm, Multi-betic, Mag-Ox, Choice DM, and DiabetiSweet primarily for people with diabetes; capsaicin products under the Zostrix name for pain management of conditions comprising arthritis and foot pain; Nasal Ease homeopathic allergy reliever; and Sinus Buster homeopathic sinus congestion reliever. Further, the company markets and distributes branded prescription pharmaceutical products to treat various disease states, including tension headache, pain, contact dermatitis, wound care, sleep disorders, and swimmer s ear. Hi Tech Pharmacal Co., Inc. market its products to chain drug stores, drug wholesalers, managed care purchasing organizations, federal government agencies, generic distributors, mass merchandisers, and mail order pharmacies. The company was founded in 1982 and is based in Amityville, New York..

MGE Energy Inc (NASDAQ:MGEE) - MGE Energy, Inc., through its subsidiaries, operates as a public utility holding company in Wisconsin. The company s Regulated Electric Utility Operations segment engages in generating, purchasing, and distributing electricity. Its Regulated Gas Utility Operations segment is involved in purchasing and distributing natural gas. The company s Nonregulated Energy Operations segment engages in constructing, owning, and leasing electric generating capacity. Its Transmission Investments segment invests in American Transmission Company LLC, which provides electric transmission services primarily in Wisconsin. The company generates electricity from coal, natural gas, fuel oil, and wind, as well as purchases power under short and long-term commitments. It owns gas fired combustion turbines that have a total of 155 megawatt (MW) net summer rated capacity; 30 MW consisting of 18 turbines in a wind-powered electric generating facility; and 11 MW consisting of 17 turbines in a wind-powered electric generating facility. The company primarily serves residential, commercial, and industrial customers, as well as public authorities, other utilities, and power marketers. As of December 31, 2012, it supplied electricity to approximately 140,000 customers in the cities of Fitchburg, Madison, Middleton, and Monona; and natural gas to approximately 145,000 customers in the cities of Elroy, Fitchburg, Lodi, Madison, Middleton, Monona, Prairie du Chien, Verona, and Viroqua. MGE Energy, Inc. was founded in 1855 and is based in Madison, Wisconsin..

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include: REGULATORY & COMPLIANCE NEWS Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

"Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 [email protected] SqueezeTrigger is a registered trademark, Reg. No. 3,120,641 CONTACT: Buyins.net Thomas Ronk [email protected] www.buyins.net ((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.com on the world wide web. Inquiries to [email protected].

[ Back To TMCnet.com's Homepage ]